MAPT and Alzheimer disease: To address this gap, the present study investigated whether direct alterations in DYRK1A gene expression in the brain alter cognitive function, neuroinflammation, and Aβ/tau pathology and elucidated the underlying mechanisms of action in WT mice and/or mouse models of AD.